Karthinathan Thangavelu Selected Research

Alemtuzumab (Campath)

11/2020	Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.
10/2020	Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years.
1/2020	Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.
9/2017	Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karthinathan Thangavelu Research Topics

Disease

8	Multiple Sclerosis 11/2020 - 03/2016
6	Relapsing-Remitting Multiple Sclerosis 11/2020 - 11/2016
3	Atrophy 01/2019 - 09/2017
2	Inflammation (Inflammations) 11/2021 - 01/2020
2	Rheumatoid Arthritis 11/2020 - 01/2019
1	Heart Diseases (Heart Disease) 11/2021
1	Diabetes Mellitus 11/2021
1	Infections 11/2021
1	COVID-19 11/2021
1	Chronic Progressive Multiple Sclerosis 10/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Necrosis 01/2020
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020
1	Wilms Tumor (Wilm's Tumor) 06/2005
1	Neoplasms (Cancer) 06/2005

Drug/Important Bio-Agent (IBA)

7	teriflunomideIBA 01/2019 - 03/2016
4	Alemtuzumab (Campath)FDA Link 11/2020 - 09/2017
2	sarilumabIBA 11/2020 - 01/2019
2	Interferon beta-1a FDA Link 01/2020 - 09/2017
2	Immunologic Factors (Immunomodulators)IBA 01/2018 - 09/2017
1	Aldehyde Reductase (Aldose Reductase)IBA 11/2021
1	caficrestatIBA 11/2021
1	tocilizumab (atlizumab)FDA Link 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	Inosine Triphosphate (ITP)IBA 01/2020
1	InterleukinsIBA 01/2020
1	dupilumabIBA 01/2020
1	Interleukin-13IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Immunoglobulin E (IgE)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Adalimumab (Humira)FDA Link 01/2019
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2016
1	Dimethyl FumarateIBA 11/2016

Therapy/Procedure

5	Therapeutics 01/2020 - 11/2016
1	Length of Stay 11/2021
1	Radiotherapy 06/2005
1	Drug Therapy (Chemotherapy) 06/2005